Okumura H, Inaba S, Kawashima A, Shimizu T
Cureus. 2024; 16(7):e64130.
PMID: 39119412
PMC: 11307240.
DOI: 10.7759/cureus.64130.
Teoli J, Chikh K, Jouini-Bouhamri R, Charriere S, Fabien N, Raverot V
Heliyon. 2024; 10(13):e34009.
PMID: 39071705
PMC: 11280251.
DOI: 10.1016/j.heliyon.2024.e34009.
Sridhar A, Renzu M, Mehta V, Hubers C, Ruby E
JCEM Case Rep. 2024; 2(7):luae129.
PMID: 39006405
PMC: 11243401.
DOI: 10.1210/jcemcr/luae129.
Perri A, Fattore S, Sbordone A, Viti L, Pitocco D, Vento G
JCEM Case Rep. 2024; 2(7):luae109.
PMID: 38952701
PMC: 11216324.
DOI: 10.1210/jcemcr/luae109.
Padarabinda Tripathy K, Pathi D, Kumar Behera P, Das S, Tarun Venkat Mahesh S
Cureus. 2024; 16(3):e56297.
PMID: 38629013
PMC: 11018556.
DOI: 10.7759/cureus.56297.
The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional survey.
Zhou L, Luo Y, Wang Y, Cheng Y, Zhang R, Zhang S
Front Clin Diabetes Healthc. 2023; 4:1172208.
PMID: 37324170
PMC: 10266272.
DOI: 10.3389/fcdhc.2023.1172208.
The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies.
Hua K, Jing B, Wu Y
Diabetes Metab Syndr Obes. 2023; 16:1121-1132.
PMID: 37122678
PMC: 10134342.
DOI: 10.2147/DMSO.S404222.
Inferring Insulin Secretion Rate from Sparse Patient Glucose and Insulin Measures.
Abohtyra R, Chan C, Albers D, Gluckman B
Front Physiol. 2022; 13:893862.
PMID: 35991187
PMC: 9384214.
DOI: 10.3389/fphys.2022.893862.
Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients.
Hua K, Zhang M, Zhang Y, Ren B, Wu Y
Diabetes Metab Syndr Obes. 2022; 15:2417-2425.
PMID: 35971523
PMC: 9375563.
DOI: 10.2147/DMSO.S373475.
Characteristics of fatal insulin overdoses.
Stephenson L, Van Den Heuvel C, Humphries M, Byard R
Forensic Sci Med Pathol. 2022; 18(4):429-441.
PMID: 35943711
PMC: 9636090.
DOI: 10.1007/s12024-022-00511-3.
Case Report: Recurrent Autoimmune Hypoglycemia Induced by Non-Hypoglycemic Medications.
Zhu Q, Zhao H, Qiu W, Wu F, Qian C, Yang Y
Front Immunol. 2022; 13:855350.
PMID: 35935967
PMC: 9352986.
DOI: 10.3389/fimmu.2022.855350.
Facilitated Qualitative Determination of Insulin, Its Synthetic Analogs, and C-Peptide in Human Urine by Means of LC-HRMS.
Thomas A, Benzenberg L, Bally L, Thevis M
Metabolites. 2021; 11(5).
PMID: 34065812
PMC: 8151387.
DOI: 10.3390/metabo11050309.
Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin.
Kay R, Barker P, Burling K, Cohen M, Halsall D, Reimann F
Clin Chem. 2021; 67(6):854-862.
PMID: 34051096
PMC: 8167340.
DOI: 10.1093/clinchem/hvab043.
Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion.
Rouland A, Bouillet B, Legris P, Simoneau I, Petit J, Verges B
Clin Pharmacol. 2021; 13:33-37.
PMID: 33574715
PMC: 7872904.
DOI: 10.2147/CPAA.S278978.
Clinical and Laboratory Aspects of Insulin Autoantibody-Mediated Glycaemic Dysregulation and Hyperinsulinaemic Hypoglycaemia: Insulin Autoimmune Syndrome and Exogenous Insulin Antibody Syndrome.
Huynh T
Clin Biochem Rev. 2020; 41(3):93-102.
PMID: 33343044
PMC: 7731936.
DOI: 10.33176/AACB-20-00008.
Insulin Autoimmune Syndrome - A Case Series.
Boro H, Gupta U, Singh C, Malhotra R, Khadgawat R
Eur Endocrinol. 2020; 16(2):168-171.
PMID: 33117451
PMC: 7572167.
DOI: 10.17925/EE.2020.16.2.168.
Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description.
Cappellani D, Macchia E, Falorni A, Marchetti P
Diabetes Metab Syndr Obes. 2020; 13:963-978.
PMID: 32308449
PMC: 7136665.
DOI: 10.2147/DMSO.S219438.
Insulin Autoimmune Syndrome in a 25-Year-Old, Previously Healthy Kuwaiti Man.
Alrashidi E, Alessa T
Case Rep Endocrinol. 2020; 2019:8919457.
PMID: 31915554
PMC: 6930746.
DOI: 10.1155/2019/8919457.
Quantile contours and allometric modelling for risk classification of abnormal ratios with an application to asymmetric growth-restriction in preterm infants.
Geraci M, Boghossian N, Farcomeni A, Horbar J
Stat Methods Med Res. 2019; 29(7):1769-1786.
PMID: 31544622
PMC: 7085954.
DOI: 10.1177/0962280219876963.
The Determination of Insulin Overdose in Postmortem Investigations.
Labay L, Bitting C, Legg K, Logan B
Acad Forensic Pathol. 2019; 6(2):174-183.
PMID: 31239889
PMC: 6507008.
DOI: 10.23907/2016.019.